US Stock Market Movements | Teva Pharmaceutical (TEVA.US) rises over 4% as innovative drug revenue in Q3 increases by 33% year-on-year
智通财经2026/11/03 15:21Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Zhihu Finance APP reported that on Tuesday, Teva Pharmaceutical (TEVA.US) rose more than 4% to $42.65, reaching a record high. In the news, Teva Pharmaceutical released its financial report for the third quarter of 2026, with non-GAAP earnings per share of $0.86, exceeding market expectations by $0.14. Revenue was $4.4 billion, down 2% year-on-year, beating market expectations by $170 million.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$75,874.2
-5.54%
Ethereum
ETH
$2,251.63
-7.17%
Tether USDt
USDT
$0.9986
-0.06%
BNB
BNB
$691.28
-3.25%
XRP
XRP
$1.24
-5.61%
USDC
USDC
$0.9996
-0.03%
Solana
SOL
$89.36
-6.67%
TRON
TRX
$0.3163
-1.19%
Zcash
ZEC
$1,251.02
-4.23%
Hyperliquid
HYPE
$78.51
-7.18%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now